Skip to content

Brown-Forman Corporation BF.A Proceeds from sales of equity securities

Proceeds from sales of equity securities at other companies

Royalty Pharma logo
Royalty PharmaRPRX
$375K
UMB Financial logo
UMB FinancialUMBF
$20.43M+270%
Evercore logo
EvercoreEVR
$0-100%
Cboe Global Markets logo
Cboe Global MarketsCBOE
$1.5M-67.4%
Ladder Capital logo
Ladder CapitalLADR
$161.96M+306%
Elevance Health logo
Elevance HealthELV
$3.09B-25.4%

Other financials

Income statement

See full
Revenue$912.0M+2.0%
Gross profit$571.0M+11.3%
Operating income$96.0M-53.2%
Net income$54.0M-63.0%
EPS (diluted)$0.12-61.3%

Balance sheet

See full
Cash & equivalents$308.0M-33.5%
Total debt$2.3B-20.3%
Total equity$4.0B+0.7%
Total assets$7.9B-2.4%

Cash flow

See full
Operating cash flow$291.0M+91.4%
CapEx$26.0M-48.0%
Free cash flow$265.0M+160%

Valuation

See full
Market cap$12.22B-26.0%
Enterprise value$14.18B-25.0%
P/E17.1×-1.9×
P/S3.1×-1.0×

Profitability

See full
Gross margin60.5%+1.6pp
Operating margin25.5%-2.4pp
Net margin18.2%-3.7pp
FCF margin22.7%+11.9pp

Returns & leverage

See full
Return on equity17.8%-5.3pp
Debt / equity0.6×-0.1×
Current ratio3.2×-0.6×

Where this comes from

Reported directly by Brown-Forman Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfEquityMethodInvestments.

The official record: Brown-Forman Corporation’s 10-K, filed June 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Brown-Forman Corporation's proceeds from sales of equity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Brown-Forman Corporation's proceeds from sales of equity securities?
Brown-Forman Corporation (BF.A) reported proceeds from sales of equity securities of $0 in Q1 2026.
What does proceeds from sales of equity securities mean?
Cash received from selling shares or equity interests in other companies.
How do you interpret proceeds from sales of equity securities?
Indicates the monetization of investment holdings to generate liquidity for other corporate purposes.
How does proceeds from sales of equity securities compare across companies?
Common in companies with significant investment portfolios or venture arms.